Open Peer Review Reports for: Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 24 Feb 2017 | Submitted | Original manuscript |
| 16 Mar 2017 | Reviewed | Reviewer Report - Tao Che |
| 18 Mar 2017 | Reviewed | Reviewer Report - Kawa Dizaye |
| 18 Apr 2017 | Author responded | Author comments - Kazuya Tsuboi |
| Resubmission - Version 2 | ||
| 18 Apr 2017 | Submitted | Manuscript version 2 |
| 20 May 2017 | Author responded | Author comments - Kazuya Tsuboi |
| Resubmission - Version 3 | ||
| 20 May 2017 | Submitted | Manuscript version 3 |
| Publishing | ||
| 26 May 2017 | Editorially accepted | |
| 7 Jun 2017 | Article published | 10.1186/s40360-017-0152-7 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
